お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989739

ウェアラブルインジェクターの市場動向・市場シェア・市場規模の予測 (2021-2028年):タイプ (オンボディ・オフボディ)・技術 (スプリングベース・モーター駆動)・用途 (腫瘍・自己免疫疾患)・エンドユーザー・地域別

Wearable Injectors Market Size, Share & Trends Analysis Report By Type (On-body, Off-body), By Technology (Spring-based, Motor-driven), By Application (Oncology, Autoimmune Diseases), By End Use, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 114 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=108.90円
ウェアラブルインジェクターの市場動向・市場シェア・市場規模の予測 (2021-2028年):タイプ (オンボディ・オフボディ)・技術 (スプリングベース・モーター駆動)・用途 (腫瘍・自己免疫疾患)・エンドユーザー・地域別
出版日: 2021年02月12日
発行: Grand View Research, Inc.
ページ情報: 英文 114 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウェアラブルインジェクターの市場規模は予測期間中17.2%のCAGRで推移し、2028年には183億米ドルの規模に成長すると予測されています。痛みが少なく、投与が簡単で、費用のかかる医療機関への通院が不要になるなどの利点があるため、ウェアラブルインジェクターの人気が高まっています。また、糖尿病、慢性疼痛、関節リウマチなどの自己免疫疾患の有病率の増加、喘息、慢性閉塞性肺疾患(COPD)、高コレステロール、癌などの長期的な管理の必要性から、同製品の需要が高まっています。

当レポートでは、世界のウェアラブルインジェクターの市場を調査し、市場の定義と概要、バリューチェーン、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・技術・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 普及・成長の見通しマッピング
  • バリューチェーン分析
  • 市場力学
  • 市場分析ツール

第4章 市場予測・動向分析:タイプ別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • オンボディ
  • オフボディ

第5章 市場予測・動向分析:技術別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • スプリングベース
  • モーター駆動
  • ロータリーポンプ
  • 拡張電池
  • その他

第6章 市場予測・動向分析:用途別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 腫瘍
  • 感染症
  • 心血管疾患
  • 自己免疫疾患
  • その他

第7章 市場予測・動向分析:エンドユーザー別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 病院
  • クリニック
  • 在宅医療
  • その他

第8章 市場予測・動向分析:地域・主要国別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
  • アジア太平洋
    • 日本
    • 中国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • 南アフリカ

第9章 競合情勢

  • 主要企業・近年の展開・影響分析
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Global Wearable Injectors Market, by Region 2016 - 2028 (USD Million)
  • Table 4 Global Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 5 Global Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 6 Global Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 7 Global Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 8 North America Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
  • Table 9 North America Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 10 North America Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 11 North America Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 12 North America Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 13 U.S. Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 14 U.S. Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 15 U.S. Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 16 U.S. Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 17 Canada Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 18 Canada Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 19 Canada Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 20 Canada Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 21 Europe Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
  • Table 22 Europe Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 23 Europe Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 24 Europe Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 25 Europe Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 26 U.K. Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 27 U.K. Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 28 U.K. Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 29 U.K. Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 30 Germany Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 31 Germany Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 32 Germany Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 33 Germany Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 34 France Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 35 France Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 36 France Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 37 France Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 38 Asia Pacific Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
  • Table 39 Asia Pacific Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 40 Asia Pacific Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 41 Asia Pacific Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 42 Asia Pacific Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 43 Japan Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 44 Japan Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 45 Japan Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 46 Japan Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 47 China Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 48 China Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 49 China Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 50 China Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 51 Latin America Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
  • Table 52 Latin America Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 53 Latin America Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 54 Latin America Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 55 Latin America Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 56 Brazil Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 57 Brazil Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 58 Brazil Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 59 Brazil Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 60 Mexico Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 61 Mexico Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 62 Mexico Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 63 Mexico Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 64 MEA Wearable Injectors Market, by Country, 2016 - 2028 (USD Million)
  • Table 65 MEA Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 66 MEA Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 67 MEA Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 68 MEA Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)
  • Table 69 South Africa Wearable Injectors Market, by Type, 2016 - 2028 (USD Million)
  • Table 70 South Africa Wearable Injectors Market, by Technology, 2016 - 2028 (USD Million)
  • Table 71 South Africa Wearable Injectors Market, by Application, 2016 - 2028 (USD Million)
  • Table 72 South Africa Wearable Injectors Market, by End Use, 2016 - 2028 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Wearable Injectors market: Market snapshot
  • Fig. 9 Wearable Injectors market: Market segmentation
  • Fig. 10 Wearable Injectors market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Wearable Injectors market driver impact
  • Fig. 14 Wearable Injectors market restraint impact
  • Fig. 15 Wearable Injectors market porter's five forces analysis
  • Fig. 16 Wearable Injectors market PESTEL analysis
  • Fig. 17 Wearable Injectors market segment dashboard
  • Fig. 18 Wearable Injectors market: Type movement Analysis
  • Fig. 19 On-body market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 20 Off-body market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 21 Wearable Injectors market segment dashboard
  • Fig. 22 Wearable Injectors market: Technology movement Analysis
  • Fig. 23 Spring-based market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 24 Motor-driven market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 25 Rotary Pump market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 26 Expanding Battery market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 28 Wearable Injectors market segment dashboard
  • Fig. 29 Wearable Injectors market: Application movement Analysis
  • Fig. 30 Oncology market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 31 Infectious diseases market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 32 Cardiovascular diseases market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 33 Autoimmune diseases market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 35 Wearable Injectors market segment dashboard
  • Fig. 36 Wearable Injectors market: End-use movement Analysis
  • Fig. 37 Hospitals market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 38 Clinics market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 39 Home care market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 40 Others market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 41 Global Wearable Injectors market: Regional movement analysis
  • Fig. 42 Global market share, by region
  • Fig. 43 North America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 44 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 45 Canada market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 46 Europe market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 47 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 48 Germany market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 49 France market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 51 Japan market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 52 China market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 53 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 54 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 55 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 56 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
目次
Product Code: GVR-1-68038-614-1

Wearable Injectors Market Growth & Trends

The global wearable injectors market size is expected to reach USD 18.3 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.2% from 2021 to 2028. Wearable injectors are drug administration devices designed to deliver drugs in large volumes subcutaneously. It is gaining popularity owing to its advantages such as reduced pain, ease of administration, and elimination of costly health facility visits.

Over the last decade, patient interest in the self-administration of injectable drug therapies has grown. The increasing prevalence of diabetes, chronic pain, and auto-immune diseases, such as rheumatoid arthritis, is increasing the use of wearable injectors. Their demand is increasing for the long-term management of asthma, chronic obstructive pulmonary disease (COPD), high cholesterol, and cancer. This is expected to create a lucrative opportunity for advanced device manufacturers to make wearable devices used to administer larger dose volumes at the comfort of home.

The recent COVID-19 pandemic has brought remote care technologies, such as wearable injectors, into the spotlight. Demand for chronic disease products remains largely unaffected by the pandemic. Since wearable injectors serve with the option of delivering medications at home, its demand has also remained stable or rather grown for the short term. Patients suffering from chronic diseases are opting for these devices as it reduces the risk of exposure to COVID-19 by eliminating hospital visits. The pandemic has, however, affected some of the devices in the pipeline, affecting short-term investments. Leading players who continue to invest in innovation push projects forward despite COVID-19 are expected to put their companies in a stronger competitive position post-crisis.

Wearable Injectors Market Report Highlights

  • By type, the on-body segment led the market in 2020 owing to its advantage to be worn on the skin
  • The spring-based technology segment held the largest share of 36.3% in 2020 due to a rise in demand for adhesive patches for the treatment of chronic conditions, such as cancer and diabetes
  • The home care end-use segment led the market in 2020. This can be attributed to a rise in preference for self-administration, especially during the COVID-19 pandemic
  • North America dominated the market with a share of 41.5% in 2020 owing to the rising prevalence of chronic diseases

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Technology
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:
    • 1.9.3. Objective 3:
    • 1.9.4. Objective 4:

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Wearable Injectors Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Reimbursement framework
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
    • 3.3.3. Industry challenges
  • 3.4. Wearable Injectors Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis
    • 3.4.4. Market Entry Strategies

Chapter 4. Wearable Injectors Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Definitions and Scope
  • 4.3. Wearable Injectors Market Share, 2020 & 2028
  • 4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 4.4.1. On-body
    • 4.4.2. Off-body

Chapter 5. Wearable Injectors Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Definitions and Scope
  • 5.3. Wearable Injectors Market Share, 2020 & 2028
  • 5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 5.4.1. Spring-based
    • 5.4.2. Motor-driven
    • 5.4.3. Rotary Pump
    • 5.4.4. Expanding Battery
    • 5.4.5. Others

Chapter 6. Wearable Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Definitions and Scope
  • 6.3. Wearable Injectors Market Share, 2020 & 2028
  • 6.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 6.4.1. Oncology
    • 6.4.2. Infectious Diseases
    • 6.4.3. Cardiovascular Diseases
    • 6.4.4. Autoimmune Diseases
    • 6.4.5. Others

Chapter 7. Wearable Injectors Market: End-use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Definitions and Scope
  • 7.3. Wearable Injectors Market Share, 2020 & 2028
  • 7.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Home Care
    • 7.4.4. Others

Chapter 8. Wearable Injectors: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2020 & 2028
  • 8.3. Regional Market Share, 2020
  • 8.4. North America
    • 8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.5.2. U.K.
      • 8.5.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. France estimates and forecast, 2016 - 2028 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 9.1.1. Becton, Dickinson and Company
      • 9.1.1.1. Company overview
      • 9.1.1.2. Financial performance
      • 9.1.1.3. Product benchmarking
      • 9.1.1.4. Strategic initiatives
    • 9.1.2. Johnson & Johnson Services, Inc.
      • 9.1.2.1. Company overview
      • 9.1.2.2. Financial performance
      • 9.1.2.3. Product benchmarking
      • 9.1.2.4. Strategic initiatives
    • 9.1.3. F. Hoffmann-La Roche Ltd.
      • 9.1.3.1. Company overview
      • 9.1.3.2. Financial performance
      • 9.1.3.3. Product benchmarking
      • 9.1.3.4. Strategic initiatives
    • 9.1.4. Unilife Corporation
      • 9.1.4.1. Company overview
      • 9.1.4.2. Financial performance
      • 9.1.4.3. Product benchmarking
      • 9.1.4.4. Strategic initiatives
    • 9.1.5. SteadyMed Therapeutics, Inc.
      • 9.1.5.1. Company overview
      • 9.1.5.2. Financial performance
      • 9.1.5.3. Product benchmarking
      • 9.1.5.4. Strategic initiatives
    • 9.1.6. Amgen Inc.
      • 9.1.6.1. Company overview
      • 9.1.6.2. Financial performance
      • 9.1.6.3. Product benchmarking
      • 9.1.6.4. Strategic initiatives
    • 9.1.7. Insulet Corporation
      • 9.1.7.1. Company overview
      • 9.1.7.2. Financial performance
      • 9.1.7.3. Product benchmarking
      • 9.1.7.4. Strategic initiatives
    • 9.1.8. Enable Injections
      • 9.1.8.1. Company overview
      • 9.1.8.2. Financial performance
      • 9.1.8.3. Product benchmarking
      • 9.1.8.4. Strategic initiatives
    • 9.1.9. West Pharmaceutical Services, Inc.
      • 9.1.9.1. Company overview
      • 9.1.9.2. Financial performance
      • 9.1.9.3. Product benchmarking
      • 9.1.9.4. Strategic initiatives
    • 9.1.10. CeQur SA
      • 9.1.10.1. Company overview
      • 9.1.10.2. Financial performance
      • 9.1.10.3. Product benchmarking
      • 9.1.10.4. Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.